ReWalk Robotics Ltd.

Equities

LFWD

IL0011331076

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:30:01 2024-04-26 pm EDT			5-day change	1st Jan Change
4.75 ^USD	+0.64%		-0.63%	-12.75%

Apr. 19	ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors	CI
Apr. 01	Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says	MT

ReWalk Robotics Ltd. Appoints Charles Remsberg as Chief Sales Officer

August 11, 2023 at 04:22 pm EDT

ReWalk Robotics Ltd. announced closing of the previously announced acquisition of AlterG Inc. In conjunction with the closing of the transaction, Charles Remsberg, former CEO of AlterG, was appointed as Chief Sales Officer of ReWalk.

Latest news about ReWalk Robotics Ltd.

ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors	Apr. 19	CI
Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says	Apr. 01	MT
ReWalk Robotics Set to Complete 1-for-7 Reverse Split of Ordinary Stock	Mar. 13	MT
ReWalk Robotics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Transcript : ReWalk Robotics Ltd., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Rewalk Robotics Ltd. Provides Earnings Guidance for the Full Year and First Quarter of 2024	Feb. 27	CI
Earnings Flash (LFWD) REWALK ROBOTICS Reports Q4 Revenue $6.9M	Feb. 27	MT
ReWalk Robotics Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) added to NASDAQ Composite Index	Jan. 30	CI
ReWalk Robotics Ltd. will Change its Name to Lifeward	Jan. 30	CI
ReWalk Robotics Ltd. will Change its Ticker to LFWD from RWLK	Jan. 30	CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) dropped from NASDAQ Composite Index	Jan. 29	CI
ReWalk Robotics Expands Direct Sales to Canada; Shares Rise	Jan. 12	MT
ReWalk Robotics Says It Successfully Demonstrates Exoskeleton Prototype	Nov. 28	MT
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype	Nov. 28	CI
ReWalk Robotics Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Transcript : ReWalk Robotics Ltd., Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Earnings Flash (RWLK) REWALK ROBOTICS Reports Q3 Revenue $4.4M	Nov. 14	MT
Transcript : ReWalk Robotics Ltd. - Special Call	Nov. 08
ReWalk Robotics Ltd. Announces Board Changes	23-09-19	CI
Declaration of Voting Results by ReWalk Robotics	23-09-19	CI
ReWalk Robotics Ltd. Announces Yasushi Ichiki Intends to Resign from Board of Directors	23-09-05	CI
ReWalk Robotics Completes Acquisition of AlterG	23-08-11	MT
ReWalk Robotics Ltd. Appoints Charles Remsberg as Chief Sales Officer	23-08-11	CI
Tranche Update on ReWalk Robotics Ltd.'s Equity Buyback Plan announced on June 2, 2022.	23-08-11	CI

Chart ReWalk Robotics Ltd.

Duration

Period

More charts

Company Profile

ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ReWalk Robotics Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4.75 USD

Average target price

63 USD

Spread / Average Target

+1,226.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
REWALK ROBOTICS LTD.	-12.75%	40.36M
STRAUMANN HOLDING AG	+1.84%	24.07B
SONOVA HOLDING AG	-6.34%	16.75B
COCHLEAR LIMITED	+8.70%	13.7B
DEMANT A/S	+10.34%	10.18B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-17.75%	2.06B
EMBLA MEDICAL HF.	+6.38%	1.79B
MODERN DENTAL GROUP LIMITED	+13.26%	589M
ANGEL ROBOTICS CO., LTD.	0.00%	400M
DELCATH SYSTEMS, INC.	+27.40%	135M

Medical Prosthetics